Related references
Note: Only part of the references are listed.Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma
Ester Simeone et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1-or Melan-A-Specific T Cells
Benjamin Weide et al.
CLINICAL CANCER RESEARCH (2014)
MELANOMA IN 2013 Melanoma-the run of success continues
Dirk Schadendorf et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Behcet's syndrome: Facts and controversies
Cem Mat et al.
CLINICS IN DERMATOLOGY (2013)
Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines
Roger M. Feakins
JOURNAL OF CLINICAL PATHOLOGY (2013)
The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
Howard L. Kaufman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
Caroline J. Voskens et al.
PLOS ONE (2013)
Ulcerative colitis
Alexander C. Ford et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Results of Interferon Alpha-2a Therapy in Patients with Behcet's Disease
F. Nilufer Yalcindag et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2012)
Application of IL-2 therapy to target T regulatory cell function
Ethan M. Shevach
TRENDS IN IMMUNOLOGY (2012)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
Claus Garbe et al.
ONCOLOGIST (2011)
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Lucy S. K. Walker et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Immune Regulatory Antibodies Are They the Next Advance?
Jedd D. Wolchok et al.
CANCER JOURNAL (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy
Axel Hoos et al.
SEMINARS IN ONCOLOGY (2010)
Immunotherapy of distant metastatic disease
D. Schadendorf et al.
ANNALS OF ONCOLOGY (2009)
The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design
Thomas A. Waldmann
NATURE REVIEWS IMMUNOLOGY (2006)
Functional CD4(+)CD25(high) regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity
Nathalie Holmen et al.
INFLAMMATORY BOWEL DISEASES (2006)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Share Paper
